ATE286716T1 - Pharmazeutische formulierungen enthaltend salmeterol - Google Patents
Pharmazeutische formulierungen enthaltend salmeterolInfo
- Publication number
- ATE286716T1 ATE286716T1 AT00977707T AT00977707T ATE286716T1 AT E286716 T1 ATE286716 T1 AT E286716T1 AT 00977707 T AT00977707 T AT 00977707T AT 00977707 T AT00977707 T AT 00977707T AT E286716 T1 ATE286716 T1 AT E286716T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical formulations
- formulations containing
- salmeterol
- containing salmeterol
- pharmaceutically acceptable
- Prior art date
Links
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004017 salmeterol Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- 150000005828 hydrofluoroalkanes Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000008249 pharmaceutical aerosol Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9927685.9A GB9927685D0 (en) | 1999-11-23 | 1999-11-23 | Pharmaceutical formulation |
| GBGB9930700.1A GB9930700D0 (en) | 1999-12-24 | 1999-12-24 | Pharmaceutical formulation |
| GB0014424A GB0014424D0 (en) | 2000-06-13 | 2000-06-13 | Pharmaceutical formulation |
| PCT/GB2000/004465 WO2001037805A1 (en) | 1999-11-23 | 2000-11-23 | Pharmaceutical formulations of salmeterol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE286716T1 true ATE286716T1 (de) | 2005-01-15 |
Family
ID=27255759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00977707T ATE286716T1 (de) | 1999-11-23 | 2000-11-23 | Pharmazeutische formulierungen enthaltend salmeterol |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP1523976A3 (de) |
| JP (1) | JP2003514841A (de) |
| AT (1) | ATE286716T1 (de) |
| AU (1) | AU1534501A (de) |
| DE (1) | DE60017450T2 (de) |
| ES (1) | ES2234694T3 (de) |
| WO (1) | WO2001037805A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2317999C (en) | 1999-09-11 | 2004-11-09 | Glaxo Group Limited | Pharmaceutical formulation of fluticasone propionate |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| AU2002351412B2 (en) | 2001-12-21 | 2010-05-20 | Exelixis Patent Company Llc | Modulators of LXR |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2326334A (en) * | 1997-06-13 | 1998-12-23 | Chiesi Farma Spa | Pharmaceutical aerosol compositions |
| US6254882B1 (en) * | 1997-09-16 | 2001-07-03 | Sepracor Inc. | Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol |
| GB9808802D0 (en) * | 1998-04-24 | 1998-06-24 | Glaxo Group Ltd | Pharmaceutical formulations |
| KR100600423B1 (ko) * | 1998-06-18 | 2006-07-13 | 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 | 2개 이상의 활성 물질을 포함하는 연무질 약제학적 제형 |
| EP1248597B1 (de) * | 1999-12-24 | 2005-03-30 | Glaxo Group Limited | Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason |
| JP5392880B2 (ja) * | 2000-05-22 | 2014-01-22 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | 加圧式定量吸入器のための安定な製薬学的溶液製剤 |
| DE10056104A1 (de) * | 2000-11-13 | 2002-05-23 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols |
-
2000
- 2000-11-23 EP EP05075040A patent/EP1523976A3/de not_active Withdrawn
- 2000-11-23 AU AU15345/01A patent/AU1534501A/en not_active Abandoned
- 2000-11-23 WO PCT/GB2000/004465 patent/WO2001037805A1/en not_active Ceased
- 2000-11-23 JP JP2001539420A patent/JP2003514841A/ja active Pending
- 2000-11-23 AT AT00977707T patent/ATE286716T1/de not_active IP Right Cessation
- 2000-11-23 EP EP00977707A patent/EP1231894B1/de not_active Expired - Lifetime
- 2000-11-23 DE DE60017450T patent/DE60017450T2/de not_active Expired - Fee Related
- 2000-11-23 ES ES00977707T patent/ES2234694T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1231894A1 (de) | 2002-08-21 |
| DE60017450D1 (de) | 2005-02-17 |
| DE60017450T2 (de) | 2006-03-02 |
| WO2001037805A1 (en) | 2001-05-31 |
| AU1534501A (en) | 2001-06-04 |
| JP2003514841A (ja) | 2003-04-22 |
| ES2234694T3 (es) | 2005-07-01 |
| EP1523976A2 (de) | 2005-04-20 |
| EP1523976A3 (de) | 2005-06-22 |
| EP1231894B1 (de) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60019167D1 (de) | Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason | |
| NO2025027I1 (no) | Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget. | |
| DE60031504D1 (de) | Fluticasonpropionat arzneizubereitung | |
| NZ298169A (en) | Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant | |
| CA2111002A1 (en) | Non-Chlorofluorocarbon Aerosol Formulations | |
| WO2001062227A3 (en) | Anticholinergic drug formulations for treatment of chronic obstr uctive pulmonary disease | |
| ATE342053T1 (de) | Formulierungen zur inhalation | |
| EP1736147A3 (de) | Fluorchlorkohlenwasserstofffreie Aerosolformulierungen | |
| MY118151A (en) | Pharmaceutical formulations containing voriconazole. | |
| ATE228823T1 (de) | Pharmazeutische aerosolformulierung | |
| CA2004598A1 (en) | Medicinal aerosol formulations | |
| PT1123120E (pt) | Formulacao medicinal em aerossol | |
| CY1112562T1 (el) | Φαρμακευτικες συνθεσεις για τη στοματικη χορηγηση της καλσιτονινης | |
| DE69828817D1 (de) | Pharmazeutische aerosolzusammensetzungen | |
| ID27554A (id) | Formulasi-formulasi sediaan farmasi untuk aerosol dengan dua atau lebih bahan aktif | |
| IL159217A0 (en) | An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine | |
| DE60017450D1 (de) | Pharmazeutische formulierungen enthaltend salmeterol | |
| WO2002000191A3 (de) | Bdellosomen | |
| BR0011845A (pt) | Complexo farmacêutico | |
| WO2002007672A3 (en) | A medicinal aerosol formulation | |
| IL152751A0 (en) | Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them | |
| WO2002041875A3 (de) | Verfahren zur herstellung leicht löslicher arzneimittelformulierungen und entsprechende formulierungen | |
| AU2001287930A1 (en) | Pharmaceutical formulation for pulmonary or nasal administration | |
| CA2446562A1 (en) | Pharmaceutical formulation of fluticasone propionate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |